Home › Atherosclerosis › Georgia › Atlanta
Atherosclerosis clinical trials in Atlanta, GA
4 studies for Atherosclerosis are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
RecruitingPhase 2
- Emory Healthcare-Emory Heart & Vascular Center - Executive Park, Atlanta
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Atlanta
- Research Site, Atlanta
- Research Site, Atlanta
- and 3 more
Pelacarsen Roll-over Extension Program
RecruitingPhase 3
- Morehouse School Of Medicine, Atlanta
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
RecruitingPhase 4
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur · 6 mi away
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Orlando, FL8 studies
- Arlington, VA8 studies
- Hialeah, FL8 studies
- Durham, NC7 studies
- Memphis, TN7 studies
- Miami, FL7 studies
- Dallas, TX7 studies
- Las Vegas, NV7 studies
- Omaha, NE6 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer47 studies
- Breast Cancer41 studies
- Multiple Myeloma41 studies
- Prostate Cancer33 studies
- Acute Myeloid Leukemia30 studies
- Ovarian Cancer29 studies
- Lung Cancer29 studies
- Colorectal Cancer29 studies
- Metastatic Cancer28 studies
- Heart Failure25 studies
- Major Depressive Disorder25 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.